Bob Cook
About Bob Cook
Bob Cook is the Senior Vice President of Research and Development at Castle Biosciences, Inc., where he has worked since 2020. He has a strong background in biochemistry and molecular biology, with extensive experience in research and development across various institutions.
Current Role at Castle Biosciences
Bob Cook serves as the Senior Vice President of Research and Development at Castle Biosciences, Inc. since 2020. In this role, he oversees the strategic direction and execution of R&D initiatives. His leadership contributes to the development of innovative diagnostic solutions in the field of oncology. Cook's experience in the industry enhances the company's research capabilities and fosters advancements in medical technology.
Previous Experience at Castle Biosciences
Prior to his current position, Bob Cook held several roles at Castle Biosciences, Inc. He served as Executive Director of R&D from 2015 to 2018, and as Vice President of Medical Affairs and R&D from 2018 to 2020. Additionally, he worked as Manager of Scientific Relations from 2011 to 2015. His tenure at Castle Biosciences has been marked by significant contributions to the company's research and development efforts.
Educational Background and Research
Bob Cook earned his Ph.D. in Biochemistry, Molecular Biology, and Cell Biology from Northwestern University, where he conducted doctoral research on protein hormones related to reproductive regulation. He also holds a B.S. degree in Molecular Biology from Temple University. His academic background laid the foundation for his extensive research career, including postdoctoral fellowships at Baylor College of Medicine and the University of California, San Diego.
Research Focus and Contributions
During his postdoctoral fellowship at Baylor College of Medicine, Bob Cook focused on the genetic regulation of rare ovarian granulosa cell tumors. At the University of California, San Diego, he evaluated the impact of glycosylation on cell function. Over his 25-year career, he has authored numerous medical and scientific publications, contributing valuable insights to the field of oncology and diagnostics.
Innovations and Patents
Bob Cook is a co-inventor on several technologies developed by Castle Biosciences. His work in designing diagnostic assays at Gen-Probe, Inc. for hematologic malignancies and solid tumors demonstrates his expertise in nucleic acid amplification technology. His contributions to innovation in medical diagnostics have been significant throughout his career.